ArticleJournal of experimental & clinical cancer research : CR2023

A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.